SYSBIOPRO
Bioproduction of pharmaceutically important iridoids: systems biology based approach
| Coordinatore | UNIVERSITEIT LEIDEN
Organization address
address: RAPENBURG 70 contact info |
| Nazionalità Coordinatore | Netherlands [NL] |
| Totale costo | 128˙151 € |
| EC contributo | 128˙151 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2009-IEF |
| Funding Scheme | MC-IEF |
| Anno di inizio | 2010 |
| Periodo (anno-mese-giorno) | 2010-09-24 - 2012-03-23 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
UNIVERSITEIT LEIDEN
Organization address
address: RAPENBURG 70 contact info |
NL (LEIDEN) | coordinator | 128˙151.40 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Plant in vitro technologies have been known for more than century. During this time, plant cell, tissue and organ cultures have become increasingly attractive and cost-effective alternatives to classical approaches for the mass production of plant metabolites. Furthermore, plant in vitro systems are the only economically feasible way of producing some high-value metabolites from rare and/or threatened plants. The progress in this field has resulted in the mass production of several important metabolites, such as taxol (paclitaxel), shikonin and berberine by different companies. However, for their production several problems had to be overcome, mainly connected with their cultivation in vitro and high sensitivity to different stress factors/conditions. Today in the postgenomic era, new functional genomic tools (transcriptomics and proteomics), enabling comprehensive investigations of biological systems, are continuously further developing and are gradually being implemented in the field of plant secondary metabolism. The latest of the “omics” is metabolomics, which is now combined with the other “omics” and such a holistic functional genomic approach forms systems biology, in which the synergism of this powerful combination opens novel avenues to fully explore the total biochemical machinery of plants. The general objective of the scientific project is to evaluate the systems biology based approach for bioproduction of pharmaceutically important iridoids from difficult-to-access and endemic Bulgarian plant species. This includes transcriptomic analyses, metabolomics and assessment of biological activities. The metabolic engineering aspects will be also covered through gene/multigene transformations. The project will finally seek for development of technology platform for iridoids production in the green cell factory.'